Shenzhen Chipscreen Biosciences Co.,Ltd.’s Net Profit Dropped 41.6% in 2022

Shenzhen Chipscreen Biosciences Co.,Ltd. (深圳微芯生物科技股份有限公司) (688321.SH) reported a net profit of 12.8 million yuan in 2022, down 41.6% year-on-year.

Meanwhile, the company posted 529.9 million yuan in revenue, up 23.1% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 45.6%.